Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
2
×
life sciences
m&a
national blog main
national top stories
new york blog main
texas blog main
texas top stories
3m
abbvie
ace
acelity
acquisition
akouos
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
apax partners
astrazeneca
biogen
biotech
bluerock therapeutics
boston blog main
botox
boulder/denver blog main
boulder/denver top stories
breast implant
breast reconstruction
buyout
cancer
cancer immunotherapy
cerovene
chase pharmaceutical corp.
china
clinical trials
covid-19
crispr
deals
debt
What
deal
2
×
ipo
ace
acelity
acquired
acquisitions
announced
antonio
bandages
billion
bio
ceo
collabs
covid
daniel
ending
gilead
gilead’s
help
introduce
maker
medicines
month
o’day
plan
plans
post
products
roundup
san
sciences
sells
transformative
valued
weeks
years
Language
unset
Current search:
allergan
×
deal
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Acelity Sells to 3M in Deal Valued at $6.7 Billion, Ending IPO Plan
